Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 6, 2005, Pages 334-339

  Mori, Yutaka ^a   Hoshino, K ^b   Yokota, K ^c   Yokose, T ^b   Tajima, N ^c  

^a Kawachi gun   (Japan)

^b PANASONIC CORPORATION   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Impaired glucose tolerance; Japanese; Metabolic syndrome; Middle aged men; Visceral fat

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSLIPIDEMIA; ETHNOLOGY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; JAPAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 21244474849     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-865680     Document Type: Article

References (25)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553
2. Bloomgarden ZT. Cardiovascular disease and diabetes. Diabetes Care 2003; 230-237
3. Burchfiel CM, Hamman RF, Marshall JA, Baxter J, Kahn LB, Amirani JJ. Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study. Am J Epidemiol. 1990; 131: 57-70
4. Cassano PA, Segal MR, Vokonas PS, Weiss ST. Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol 1990; 1: 33-48
5. s DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group, European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe. Lancet 1999; 354: 617-621
6. The Examination Committee of Criteria for "Obesity Disease" in Japan, Japan Society for the Study of Obesity. Novel criteria for "obesity disease" in Japan. Circ J 2002; 66: 987-992
7. The Expert Committee. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999; 22: S5-S19
8. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
9. Foster C, Rotimi C, Fraser H, Sundarum C, Liao Y, Gibson E, Holder Y, Hoyos M, Mellanson-King R. Hypertension, diabetes, and obesity in Barbados; findings from a recent population-based survey. Ethn Dis 1993; 3: 404-412
10. Fuller JH, Shpley MJ, Rose G, Jarrett RJ, and Keen HC. Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet 1980; 1: 1373-1376
11. Hanefeld M, Tamelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 1999; 16: 212-218
12. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002; 51: 3120-3127
13. Jarrett RJ, Keen H, Fuller JH, and McCartney P. Worsening of diabetes in men with impaired glucose tolerance. Diabetologia 1979; 16: 25-30
14. Kashyap VS, Santamarina-Fojo S, Brown DR, Parrott CL, Applebaum-Bowden D, Meyn S, Talley G, Paigen B, Maeda N, Brewer HB Jr. Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest 1995; 96: 1612-1620
15. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716
16. Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol 1996; 7: 217-226
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment - insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
18. Meigs JB. The metabolic syndrome. BMJ 2003; 327: 61-62
19. Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, Islam AH, Keno Y, Kobatake T, Nagai Y et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis. 1994; 107: 239-246
20. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993; 44: 121-131
21. Schoen RE, Thaete FL, Weissfeld JL, Sankey SS, Weissfeld JL, Kuller LH. Sagittal diameter in comparison with single slice CT as a predictor of total visceral adipose tissue volume. Int J Obes Relat Metab Disord 1998; 22: 338-342
22. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924
23. Wajchenberg BL. Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome. Endocrine Rev 2000; 21: 697-738
24. Wareham NJ, Phillip DI, Byrne CD. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 1995; 12: 931
25. Yoshizumi T, Nakamura T, Yamane M, Hasan AM, Islam W, Menju M, Yamasaki K. Abdominal fat: Standardized technique for measurement at CT. Radiology 1999; 211: 283-286